Tag Archives: U.S.

Vertex Announces U.S. FDA Approval for Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations

BOSTON–(BUSINESS WIRE)–Jun. 9, 2021– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved expanded use of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis (CF) ages 6 through 11 years who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a… Read More »

Royal Caribbean CEO, after months of cajoling, praises CDC’s new path to resume U.S. cruises

Royal Caribbean CEO Richard Fain on Thursday cheered the Centers for Disease Control and Prevention’s updated coronavirus policies for resumption of cruises from U.S. ports. “We’re really very pleased and very excited because it really does set forth a pathway that we think is achievable, practical and safe,” Fain said on CNBC’s “Squawk on the Street.”… Read More »

Even Before COVID, Many More People Died Early in U.S. Versus Europe

THURSDAY, April 15, 2021 — Americans were living shorter lives and dying at a significantly higher rate than the citizens of wealthy European countries even before the COVID-19 pandemic struck, a new study reports. The United States suffered more than 400,000 excess deaths in 2017 alone, pre-COVID, compared to the combined populations of France, Germany,… Read More »